PCVX financials
Vaxcyte (PCVX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PCVX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$923.67M | -$766.63M | -5.63 |
| 2024 | $0.00 | $0.00 | -$569.55M | -$463.93M | -3.80 |
| 2023 | $0.00 | $0.00 | -$468.04M | -$402.27M | -4.14 |
| 2022 | $0.00 | $0.00 | -$232.26M | -$223.49M | -3.44 |
| 2021 | $0.00 | $0.00 | -$103.67M | -$100.08M | -1.93 |
| 2020 | $0.00 | -$1.41M | -$89.58M | -$89.22M | -2.97 |